Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Summary of Segment Performance (Details)

v3.10.0.1
Segment Reporting - Summary of Segment Performance (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting Information [Line Items]        
Net revenue $ 2,064 $ 1,291 $ 4,269 $ 3,933
Cost of revenue 1,280 693 3,006 2,507
Gross profit 784 598 1,263 1,426
Vascular [Member]        
Segment Reporting Information [Line Items]        
Net revenue 789 43 973 68
Cost of revenue 579 52 1,050 60
Gross profit 210 (9) (77) 8
Dermatology [Member]        
Segment Reporting Information [Line Items]        
Net revenue 1,275 1,248 3,296 3,865
Cost of revenue 701 641 1,956 2,447
Gross profit $ 574 $ 607 $ 1,340 $ 1,418